Want to see MEDS full AI Analyst Report?
DataMeds AI (MEDS) Ownership Overview
The ownership structure of DataMeds AI (MEDS) stock is a mix of institutional, retail, and individual investors. , 11.96% is owned by Insiders, and 87.28% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 282,365 | Insider | 6.25% | 542,141 | |
| 257,645 | Insider | 5.71% | 494,678 | |
| 14,157 | Institution | 0.31% | 27,181 | |
| 11,085 | Institution | 0.25% | 21,283 | |
| 9,059 | Institution | 0.20% | 17,393 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,157 | Institution | 0.31% | 27,181 | |
| 11,085 | Institution | 0.25% | 21,283 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,059 | Institution | 0.20% | 28,717 |
FAQ
Who Owns DataMeds AI (MEDS)?
Currently, no data Available
What percentage of DataMeds AI (MEDS) stock is held by institutional investors?
Currently, no data Available
What percentage of DataMeds AI (MEDS) stock is held by retail investors?
According to the latest TipRanks data, approximately 87.28% of DataMeds AI (MEDS) stock is held by retail investors.
Who owns the most shares of DataMeds AI (MEDS)?
Prashant Patel owns the most shares of DataMeds AI (MEDS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.